The Effectiveness of Peer-education Programs for Adolescents Diagnosed With Asthma

April 26, 2024 updated by: Emine Güneş Şan, Bartın Unıversity

Evaluation of the Effectiveness of a Technology-based Program Delivered by Peer-led and Adult Educators to Adolescents Diagnosed With Asthma

The research was planned in a randomized controlled trial to evaluate the effect of technology-based education provided by peers and adults to children diagnosed with asthma in the 12-18 age group. The study will be conducted in two phases. The initial phase will assess the efficacy of the training provided to peer mentors. The subsequent phase will examine the impact of peer-led and adult-delivered technology-based education on quality of life, asthma control, asthma knowledge, and self-efficacy in adolescents diagnosed with asthma. The required institutional permission and ethics committee approval was received. The study group of the study will consist of 45 adolescents (intervention group 1 [n=15], intervention group 2 [n=15], and control group [n=15]). Data will be collected by using the descriptive features form, the Adolescent Asthma Self-Efficiacy Questionaire, the Asthma Quality of Life Scale for Children, the Asthma Control Test, the Asthma Knowledge Test.The data will be analyzed using the SPSS 27 program.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Asthma is the most common chronic disease in children. Although asthma often occurs in childhood, it can occur at any age. The incidence and prevalence of asthma is higher in children. On average, 5-10% of the world's population has an individual diagnosed with asthma, and one-third of these individuals are under the age of 18. In the United States of America (USA), approximately 6 million children between the ages of 0-17 are diagnosed with asthma. It has been reported that adolescents are at high risk for poor asthma outcomes, and death rates from asthma are twice as high in the 11-17 age group than in the 0-10 age group.

Peer relationships and peer support are of particular importance for children with chronic illnesses. Adolescents diagnosed with asthma value support from their peers. Adolescents tend to seek guidance from people with similar characteristics, and the opinions of individuals with similar characteristics are more valuable than those of individuals who do not have similar characteristics. Being with an adolescent diagnosed with asthma can improve the adolescent's sense of support and sense of normalcy. It is crucial to create an environment where adolescents diagnosed with asthma can interact with other adolescents diagnosed with asthma, thereby facilitating the formation of a support network.The research was planned in a randomized controlled trial to evaluate the effect of technology-based education provided by peers and adults to children diagnosed with asthma in the 12-18 age group. The study group of the study will consist of 45 adolescents (intervention group 1 [n=15], intervention group 2 [n=15], and control group [n=15]). The technology-based program will be applied to adolescents for 4-6 weeks through modules on the website. At the end of the study, it will apply website modules to the adolescents in the control group. The research is based on the Bandura's Self-Efficacy Theory.

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey
      • Ankara, Turkey
        • Emine Gunes San
        • Contact:
        • Sub-Investigator:
          • Naime Altay, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The study population is comprised of individuals between the ages of 12 and 18 who have been diagnosed with asthma at least three months prior and who do not have any other medical diagnoses of chronic disease. Additionally, they must own and be able to use a smartphone, reliable home internet access, and a computer. Furthermore, they must be proficient in Turkish and not be in the active attack period. Finally, they must not have experienced a stressful event that could affect their quality of life in the last three months, such as an acute illness, the birth of a new sibling, or the death of a family member.

Exclusion Criteria:

  • Those who are unwilling or unable to continue the research Those who fail to participate in the internet-based application on two or more occasions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Peer Group
-The experimental group that will apply the technology-based psychosocial program from peers
Other: Technology Based Asthma Program
Evaluate the impact of peer-led and adult-based technology-based education on the quality of life, asthma control, asthma knowledge and self-efficacy in adolescents diagnosed with asthma.
Other: Adult Group
-The group that will apply the technology-based psychosocial program from adult
Other: Technology Based Asthma Program
Evaluate the impact of peer-led and adult-based technology-based education on the quality of life, asthma control, asthma knowledge and self-efficacy in adolescents diagnosed with asthma.
No Intervention: Control Group
Control group that will no apply the technology-based psychosocial program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adolescent Asthma Self-Efficacy Questionnaire
Time Frame: Change from Baseline level to 3 months (change is being assessed)
The scale is applied to adolescents aged 12-18 with a diagnosis of asthma. Scale items are scored from 0 to 100. The responses to the scale items are added and then divided by 27 to obtain the total average score (0-100). Subscale items are added in the same way and divided by the number of items in each subscale. A higher score indicates higher self-efficacy.
Change from Baseline level to 3 months (change is being assessed)
Asthma Quality of Life Scale for Children
Time Frame: Change from Baseline level to 3 months (change is being assessed)
The instrument was developed to assess the physical, mental and social disorders of children diagnosed with asthma in the 7-17 age group. The scores range from 23 to 161. The items on the scale are evaluated using a 7-point Likert scale. A high score indicates a high quality of life, while a low score indicates a low quality of life.
Change from Baseline level to 3 months (change is being assessed)
Asthma Control Test
Time Frame: Change from Baseline level to 3 months (change is being assessed)
The Asthma Control Test (ACT) is a five-item instrument designed to assess asthma control. The ACT scores range from 5 to 25, with a score of 5 indicating poor asthma control and a score of 25 indicating complete control of asthma. A score below 19 is generally used to indicate uncontrolled asthma.
Change from Baseline level to 3 months (change is being assessed)
Asthma knowledge test
Time Frame: Change from Baseline level to 3 months (change is being assessed)
This form will be created by researchers in accordance with the existing literature. It will be used to evaluate information about asthma symptoms, triggers and treatment. The form will be created in a 3-point Likert type as "True", "False" and "I don't know". In the form, each correct answer will receive "1 point", while incorrect answers and those marked "I don't know" will receive "0 points". A high total score obtained from this form will indicate a high level of knowledge about asthma.
Change from Baseline level to 3 months (change is being assessed)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bartın Unıversity

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

April 26, 2024

First Submitted That Met QC Criteria

April 26, 2024

First Posted (Actual)

April 30, 2024

Study Record Updates

Last Update Posted (Actual)

April 30, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-Gazi-SBE-E.896440

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There are no plans to make individual participant data (IPD) available to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Technology Based Asthma Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe